查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625477

铂类抗癌药物市场规模、占有率、趋势、行业分析报告（按类型、应用、分销管道和地区）- 市场预测，2025-2034 年

Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type, Application, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，全球铂类抗癌药物市场预计到2034年将达到27.3324亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场的成长进行了分析。

卵巢癌、肺癌和大肠直肠癌等各种癌症的发生率不断上升，这些癌症需要有效的化疗，这推动了铂类抗癌药物市场的成长。主要的市场推动因素包括顺铂、卡铂和奥沙利铂等铂类药物在治疗实体瘤方面的持续有效性、联合疗法的进步以及改善治疗结果的个人化医疗。新兴市场也存在机遇，因为这些市场的癌症治疗管道正在不断扩大，而新药配方的开发也旨在减少副作用和改善药物传输。

铂基抗癌药物的市场趋势，例如联合疗法的增加、对降低毒性的注重以及铂类药物仿製药的增加，可能会在预测期内促进整体市场的扩张。随着铂类药物研究的进步和新用途的探索，预计市场将继续成长，以满足对更好的癌症治疗的需求和全球对更便宜治疗的需求。

铂类抗癌药物市场报告重点

按类型划分，顺铂因其在治疗包括卵巢癌和睪丸癌在内的各种癌症方面的长期有效应用而占据铂类癌症治疗市场占有率的主导地位。不过，应用于结肠癌治疗及合併治疗的奥沙利铂类药物成长速度最快。

由于顺铂和卡铂等铂类药物具有较高的治疗效果，卵巢癌在应用领域占据了最大的市场占有率。肺癌是成长最快的领域，主要是由于非小细胞肺癌发生率的增加以及铂类药物与其他药物的联合使用。

根据分销管道，市场由医院药房主导，医院药房是住院和癌症治疗化疗药物（包括铂类药物）的主要供应商。受远距医疗趋势以及患者续药和门诊护理便利性的提高的推动，网路药局正经历最快的成长。

北美占据全球市场的最大占有率，这主要归功于该地区先进的医疗保健基础设施和较高的癌症发病率。亚太地区是成长最快的地区，主要原因是癌症发生率上升、医疗保健机会改善以及中国和印度等国家对铂类药物的采用增加。

目录

第 1 章简介

第 2 章执行摘要

第 3 章 研究方法

第 4 章。
  • 市场概况
  • 铂类抗癌药物市场动态
    • 推动因素和机遇
      • 越来越多采用铂类癌症化疗
      • 正在进行的联合疗法研究
    • 阻碍因素和课题
      • 成本高
  • PESTEL 分析
  • 铂类抗癌药物市场通路趋势
  • 价值链分析
  • COVID-19 影响分析

第 5 章。
  • 主要发现
  • 简介
  • 顺铂
  • 奥沙利铂
  • 卡铂
  • 其他

6. 全球铂类肿瘤药物市场（依应用）

  • 主要发现
  • 简介
  • 大肠癌
  • 卵巢癌
  • 肺癌
  • 其他

7. 全球铂类肿瘤药物市场依通路划分

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

8. 全球铂类肿瘤药物市场（按地区）

  • 主要发现
  • 简介
      铂类肿瘤药物市场评估（地区），2020 年至 2034 年
  • 北美洲
      2020 年至 2034 年北美各类型
    • 2020 年至 2034 年北美各应用领域 2020 年至 2034 年北美按通路划分
    • 美国
    • 加拿大
  • 欧洲
      2020 年至 2034 年欧洲各类型 2020 年至 2034 年欧洲应用状况 2020 年至 2034 年欧洲按通路划分
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
    亚太地区
      2020 年至 2034 年亚太地区各类产品 2020 年至 2034 年亚太地区应用情况 2020 年至 2034 年亚太地区通路分布
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
      2020 年至 2034 年中东和非洲各类型 2020 年至 2034 年中东和非洲的应用状况 2020 年至 2034 年中东和非洲按分销管道划分
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
      2020 年至 2034 年拉丁美洲各类型
    • 2020 年至 2034 年拉丁美洲各应用领域状况 2020 年至 2034 年拉丁美洲按通路划分
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第 9 章 竞争格局

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协定/揭露

第十章 公司简介

  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi
  • Pfizer
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical Industries
  • Hikma Pharmaceuticals
  • Mylan
  • AstraZeneca
  • GlaxoSmithKline
  • Bayer
  • Merck & Co.
  • Amgen
  • Sun Pharmaceutical Industries
Product Code: PM1635

The global platinum-based cancer drugs market size is expected to reach USD 2,733.24 million by 2034, according to a new study by Polaris Market Research. The report "Platinum-Based Cancer Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Cisplatin, Oxaliplatin, Carboplatin, and Others), Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle, East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of various cancers, such as ovarian, lung, and colorectal cancer, that require effective chemotherapy treatments drives the platinum-based cancer drugs market growth. Key market growth drivers include the continued effectiveness of platinum-based drugs such as cisplatin, carboplatin, and oxaliplatin in treating solid tumors and advancements in combination therapies and personalized medicine that enhance treatment outcomes. Opportunities exist in emerging markets where access to cancer treatments is expanding, as well as in the development of new drug formulations aimed at reducing side effects and improving drug delivery.

A few platinum-based cancer drugs market trends such as the rise of combination therapies, the focus on reducing toxicity, and the growing availability of generic platinum drugs would contribute to the market's overall expansion during the forecast period. As research progresses and new applications for platinum-based drugs are explored, the market is poised for continued growth, addressing both the demand for better cancer treatments and the need for affordable therapies worldwide.

Platinum-Based Cancer Drugs Market Report Highlights

Based on type, the Cisplatin segment dominates the platinum-based cancer drugs market share due to its long-standing use and effectiveness in treating various cancers, including ovarian and testicular cancer. However, the oxaliplatin segment is the fastest-growing, driven by its increasing application in colorectal cancer treatments and combination therapies.

The ovarian cancer segment, by application, holds the largest market share, owing to the high efficacy of platinum-based drugs such as cisplatin and carboplatin in treating this cancer. Lung cancer is the fastest-growing segment, primarily due to the rising incidence of non-small cell lung cancer and the use of platinum-based therapies in combination with other drugs.

By distribution channel, the hospital-based pharmacies segment dominates the market as they are the primary providers of chemotherapy drugs, including platinum-based treatments, for inpatient care and cancer treatments. Online pharmacies are experiencing the highest growth, driven by the increasing trend of remote healthcare and patient convenience for prescription refills and outpatient treatments.

North America holds the largest share of the global market, largely due to advanced healthcare infrastructure and high cancer incidence rates in the region. Asia Pacific is the highest-growing region, fueled by the increasing cancer burden, improving healthcare access, and rising adoption of platinum-based therapies in countries such as China and India.

Polaris Market Research has segmented the platinum-based cancer drugs market report on the basis of type, application, distribution channel, and region:

By Type Outlook (Revenue - USD Million, 2020-2034)

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others

By Application Outlook (Revenue - USD Million, 2020-2034)

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

  • Hospital-Based Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Platinum-Based Cancer Drugs Market Insights

  • 4.1. Platinum-Based Cancer Drugs Market - Market Snapshot
  • 4.2. Platinum-Based Cancer Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Adoption of Platinum-Based Chemotherapy in Cancer Treatment
      • 4.2.1.2. Ongoing Research in Combination Therapies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Platinum-Based Cancer Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Platinum-Based Cancer Drugs Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • 5.3. Cisplatin
    • 5.3.1. Global Platinum-Based Cancer Drugs Market, by Cisplatin, by Region, 2020-2034 (USD Million)
  • 5.4. Oxaliplatin
    • 5.4.1. Global Platinum-Based Cancer Drugs Market, by Oxaliplatin, by Region, 2020-2034 (USD Million)
  • 5.5. Carboplatin
    • 5.5.1. Global Platinum-Based Cancer Drugs Market, by Carboplatin, by Region, 2020-2034 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

6. Global Platinum-Based Cancer Drugs Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • 6.3. Colorectal Cancer
    • 6.3.1. Global Platinum-Based Cancer Drugs Market, by Colorectal Cancer, by Region, 2020-2034 (USD Million)
  • 6.4. Ovarian Cancer
    • 6.4.1. Global Platinum-Based Cancer Drugs Market, by Ovarian Cancer, by Region, 2020-2034 (USD Million)
  • 6.5. Lung Cancer
    • 6.5.1. Global Platinum-Based Cancer Drugs Market, by Lung Cancer, by Region, 2020-2034 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Platinum-Based Cancer Drugs Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Platinum-Based Cancer Drugs Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.3. Hospital-Based Pharmacies
    • 7.3.1. Global Platinum-Based Cancer Drugs Market, by Hospital-Based Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Platinum-Based Cancer Drugs Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Platinum-Based Cancer Drugs Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Platinum-Based Cancer Drugs Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Platinum-Based Cancer Drugs Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Platinum-Based Cancer Drugs Market - North America
    • 8.3.1. North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.3.2. North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.3.3. North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.4. Platinum-Based Cancer Drugs Market - U.S.
      • 8.3.4.1. U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.5. Platinum-Based Cancer Drugs Market - Canada
      • 8.3.5.1. Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.4. Platinum-Based Cancer Drugs Market - Europe
    • 8.4.1. Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.4.2. Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.4.3. Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.4. Platinum-Based Cancer Drugs Market - UK
      • 8.4.4.1. UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.5. Platinum-Based Cancer Drugs Market - France
      • 8.4.5.1. France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.5.2. France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.5.3. France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.6. Platinum-Based Cancer Drugs Market - Germany
      • 8.4.6.1. Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.7. Platinum-Based Cancer Drugs Market - Italy
      • 8.4.7.1. Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.8. Platinum-Based Cancer Drugs Market - Spain
      • 8.4.8.1. Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.9. Platinum-Based Cancer Drugs Market - Netherlands
      • 8.4.9.1. Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.10. Platinum-Based Cancer Drugs Market - Russia
      • 8.4.10.1. Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.11. Platinum-Based Cancer Drugs Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.5. Platinum-Based Cancer Drugs Market - Asia Pacific
    • 8.5.1. Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.4. Platinum-Based Cancer Drugs Market - China
      • 8.5.4.1. China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.4.2. China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.4.3. China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.5. Platinum-Based Cancer Drugs Market - India
      • 8.5.5.1. India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.5.2. India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.5.3. India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.6. Platinum-Based Cancer Drugs Market - Malaysia
      • 8.5.6.1. Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.7. Platinum-Based Cancer Drugs Market - Japan
      • 8.5.7.1. Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.8. Platinum-Based Cancer Drugs Market - Indonesia
      • 8.5.8.1. Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.9. Platinum-Based Cancer Drugs Market - South Korea
      • 8.5.9.1. South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.10. Platinum-Based Cancer Drugs Market - Australia
      • 8.5.10.1. Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.11. Platinum-Based Cancer Drugs Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.6. Platinum-Based Cancer Drugs Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.4. Platinum-Based Cancer Drugs Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.5. Platinum-Based Cancer Drugs Market - UAE
      • 8.6.5.1. UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.6. Platinum-Based Cancer Drugs Market - Israel
      • 8.6.6.1. Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.7. Platinum-Based Cancer Drugs Market - South Africa
      • 8.6.7.1. South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.8. Platinum-Based Cancer Drugs Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.7. Platinum-Based Cancer Drugs Market - Latin America
    • 8.7.1. Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.4. Platinum-Based Cancer Drugs Market - Mexico
      • 8.7.4.1. Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.5. Platinum-Based Cancer Drugs Market - Brazil
      • 8.7.5.1. Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.6. Platinum-Based Cancer Drugs Market - Argentina
      • 8.7.6.1. Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.7. Platinum-Based Cancer Drugs Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bristol-Myers Squibb
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Eli Lilly and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Sanofi
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Pfizer
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Johnson & Johnson
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Teva Pharmaceutical Industries
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Hikma Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mylan
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. AstraZeneca
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. GlaxoSmithKline
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Bayer
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Merck & Co.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Amgen
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sun Pharmaceutical Industries
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables:

  • Table 1 Global Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 2 Global Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 4 North America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 5 North America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 6 North America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 U.S.: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 8 U.S.: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 9 U.S.: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 10 Canada: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 11 Canada: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 12 Canada: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 14 Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 15 Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 16 UK: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 17 UK: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 18 UK: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 France: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 20 France: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 21 France: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 22 Germany: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 23 Germany: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 24 Germany: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Italy: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 26 Italy: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 27 Italy: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 28 Spain: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 29 Spain: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 30 Spain: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 Netherlands: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 32 Netherlands: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 33 Netherlands: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 34 Russia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 35 Russia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 36 Russia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 China: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 44 China: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 45 China: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 46 India: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 47 India: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 48 India: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 Malaysia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 50 Malaysia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 51 Malaysia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 52 Japan: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 53 Japan: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 54 Japan: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Indonesia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 56 Indonesia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 57 Indonesia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 58 South Korea: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 59 South Korea: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 60 South Korea: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Australia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 62 Australia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 63 Australia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 73 UAE: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 74 UAE: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 75 UAE: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 76 Israel: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 77 Israel: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 78 Israel: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 79 South Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 80 South Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 81 South Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 85 Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 86 Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 87 Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 88 Mexico: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 89 Mexico: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 90 Mexico: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 91 Brazil: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 92 Brazil: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 93 Brazil: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 94 Argentina: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 95 Argentina: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 96 Argentina: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Type, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Application, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Platinum-Based Cancer Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global Platinum-Based Cancer Drugs Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Platinum-Based Cancer Drugs Market, by Type, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Platinum-Based Cancer Drugs Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Platinum-Based Cancer Drugs Market, by Distribution Channel, 2024 & 2034 (USD Million)